
J.M. Smucker Company reported strong fiscal Q4 results, surpassing earnings per share and revenue expectations. The company maintains a Buy rating due to attractive valuation and technical factors, with shares trading over 20% below fair value based on a conservative price-to-earnings ratio of 13. It offers a high free cash flow yield of 9% and a dividend yield of 4.3%. Despite an anticipated 3-4% sales decline, guidance for fiscal year 2027 projects adjusted EPS between $9.75 and $10.25 and $1 billion in free cash flow. Key risks include rising input costs, a weaker U.S. consumer market, impacts from GLP-1 drugs, and potential margin pressures from labor and interest rate increases.